Models for open innovation in the pharmaceutical industry.

The nature of the pharmaceutical industry is such that the main driver for its growth is innovation. In view of the vast challenges that the industry has been facing for several years and, in particular, how to manage stagnating research and development (R&D) productivity, pharmaceutical companies have opened their R&D organizations to external innovation. Here, we identify and characterize four new types of open innovator, which we call 'knowledge creator', 'knowledge integrator', 'knowledge translator' and 'knowledge leverager', and which describe current open R&D models.

Topotactic transformations of sodalite cages: synthesis and NMR study of mixed salt-free and salt-bearing sodalites.

A series of mixed sodalite samples, Na(8)[Al(6)Si(6)O(24)]Br(x).(H(3)O(2))(2-x), with the unit cell stoichiometries varying in the 0 < x <2 region, was made by hydrothermal synthesis and subsequently transformed into Na(6+x)[Al(6)Si(6)O(24)]Br(x).(4H(2)O)(2-x) and Na(6+x)[Al(6)Si(6)O(24)]Br(x).